Primary Systemic Amyloidosis — Trials

Primary Systemic Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01078454	Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis	completed	Phase 3	11	National Cancer Institute (NCI)NIH	1	Feb 1, 2022	clinicaltrials
NCT00344526	Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis	completed	Phase 3	100	University Hospital, LimogesOTHER	1	Jun 28, 2007	clinicaltrials

Data updated 22 days agoSource updated Feb 1, 2022source: clinicaltrials